Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
CORE 2022

Video Series

Author(s): Jonathan Hill , James Spratt , Charalambos Antoniades , et al Added: 1 year ago
Millbrook Medical Conferences, in association with Abbott and Radcliffe Cardiology, proudly introduce the6thannual CORE meeting, brought to you live and in person from the Royal College of Physicians, London. CORE 2022assembles world renowned experts to discuss and demonstrate how we can optimise PCI outcomes, together as a community. Innovative lectures and live cases address the appropriate… View more
Author(s): William R Colyer Jr , Christopher J Cooper Added: 3 years ago
Renal artery stenosis (RAS) is a common manifestation of atherosclerotic disease. Although the exact prevalence rate for the population as a whole is unknown, RAS is seen in a significant proportion of patients who present with another manifestation of atherosclerosis (Table 1).1–7 Despite this high degree of prevalence, the management of RAS, specifically the role of revascularisation, remains… View more
Author(s): Roberto Diletti Added: 6 years ago
Interview with Dr Roberto Diletti from Erasmus Medical Centre, Rotterdam, The Netherlands on Revascularisation Strategies in STEMI and Multi Vessel DiseasePatients. Filmed by Radcliffe Cardiology on-site at EuroPCR 2017. View more
Author(s): Mamas A Mamas , Shamir Mehta Added: 4 years ago
Prof Mamas Mamas (University of Keele, Staffordshire, UK) and Prof Shamir Mehta (McMaster University, Ontario, CA) discuss the challenges and implications of complete revascularisation with multi-vessel PCI in STEMI. Filmed on site at ESC 2019 by Radcliffe Cardiology Videography: Mike Knight & Tom Green View more
Author(s): Raffaele De Caterina , Carlo De Innocentiis , Marco Zimarino Added: 3 years ago
Multivessel coronary artery disease (MVCAD) is defined by the presence of ≥50% diameter stenosis of two or more epicardial coronary arteries. The presence of MVCAD indicates poorer prognosis and a significantly higher mortality than single-vessel disease. In MVCAD, revascularisation can be achieved by either percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG).1,2 A… View more
Author(s): Daniel S Menees , Eric R Bates Added: 3 years ago
Nearly one-third of the approximately 30 million people undergoing non-cardiac surgery in the US each year have known coronary artery disease (CAD) or CAD risk factors.1,2 An estimated one million suffer peri-operative cardiac complications accounting for roughly US$20 billion in annual medical costs.3 Peri-operative myocardial infarction (MI) may affect as many as 34% of high-risk individuals… View more
Author(s): Davide Cao , Mauro Chiarito , Paolo Pagnotta , et al Added: 3 years ago
The prevalence of concomitant coronary artery disease (CAD) in patients with severe aortic stenosis (AS) varies widely among different reports. This depends primarily on the definition used to assess CAD as well as study design and patient selection, therefore making a uniform estimate difficult. Major trials investigating transcatheter aortic valve implantation (TAVI) highlighted a substantial… View more